Company Announcement no. 16 /2016
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 1 July 2016
Notice to Convene Extraordinary General Meeting
The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (the "Company"), hereby convenes an extraordinary general meeting in the Company to be held on
Tuesday 26 July 2016 at 1 pm.
at the offices of Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen, Denmark.
Agenda
1 Election of members of the board of directors
2 The board of directors' report on the financial situation of the Company following loss of share capital
3 Proposal from the board of directors on authorization of the chairman of the extraordinary general meeting
